ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Guimin Xia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3155-1281; OpenAlex author ID A5007045422. Sources: OpenAlex.

Their work

Papers: 4 (first author 0, last author 3)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 10

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 2 papers

Papers 4

Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer. Last author DOI 10.1016/j.jconrel.2023.11.028 ↗
Improved Antitumor Efficiency of N4 -Tetradecyloxycarbonyl Gemcitabine-Loaded Liposomes for Pancreatic Cancer Chemotherapy. Last author DOI 10.2147/ijn.s485861 ↗
Miriplatin-loaded liposome, as a novel mitophagy inducer, suppresses pancreatic cancer proliferation through blocking POLG and TFAM-mediated mtDNA replication. Co-author DOI 10.1016/j.apsb.2023.07.009 ↗
Promoted antitumor therapy on pancreatic cancer by a novel recombinant human albumin-bound miriplatin nanoparticle. Last author DOI 10.1016/j.ejps.2021.106000 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaowei Wang · 4 shared papers, 2021–2024 · strength 0.76
Mingliang Liu · 2 shared papers, 2024 · strength 0.41
- Paper Improved Antitumor Efficiency of N4 -Tetradecyloxycarbonyl Gemcitabine-Loaded Liposomes for Pancreatic Cancer Chemother… DOI 10.2147/ijn.s485861 ↗
- Paper Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer. DOI 10.1016/j.jconrel.2023.11.028 ↗
Dan Wang · 2 shared papers, 2021–2024 · strength 0.34
- Paper Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer. DOI 10.1016/j.jconrel.2023.11.028 ↗
- Paper Promoted antitumor therapy on pancreatic cancer by a novel recombinant human albumin-bound miriplatin nanoparticle. DOI 10.1016/j.ejps.2021.106000 ↗
Wuli Zhao · 1 shared paper, 2023 · strength 0.22
- Paper Miriplatin-loaded liposome, as a novel mitophagy inducer, suppresses pancreatic cancer proliferation through blocking P… DOI 10.1016/j.apsb.2023.07.009 ↗
Rong‐Guang Shao · 1 shared paper, 2023 · strength 0.22
- Paper Miriplatin-loaded liposome, as a novel mitophagy inducer, suppresses pancreatic cancer proliferation through blocking P… DOI 10.1016/j.apsb.2023.07.009 ↗
Yan Li · 1 shared paper, 2024 · strength 0.21
- Paper Improved Antitumor Efficiency of N4 -Tetradecyloxycarbonyl Gemcitabine-Loaded Liposomes for Pancreatic Cancer Chemother… DOI 10.2147/ijn.s485861 ↗
Dan Wang · 1 shared paper, 2024 · strength 0.21
- Paper Improved Antitumor Efficiency of N4 -Tetradecyloxycarbonyl Gemcitabine-Loaded Liposomes for Pancreatic Cancer Chemother… DOI 10.2147/ijn.s485861 ↗
Hongwei Lü · 1 shared paper, 2024 · strength 0.20
- Paper Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer. DOI 10.1016/j.jconrel.2023.11.028 ↗
Jie Ma · 1 shared paper, 2021 · strength 0.13
- Paper Promoted antitumor therapy on pancreatic cancer by a novel recombinant human albumin-bound miriplatin nanoparticle. DOI 10.1016/j.ejps.2021.106000 ↗
Qingfang Miao · 1 shared paper, 2021 · strength 0.13
- Paper Promoted antitumor therapy on pancreatic cancer by a novel recombinant human albumin-bound miriplatin nanoparticle. DOI 10.1016/j.ejps.2021.106000 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.